-
1 week ago | 
insights.citeline.com | Natasha Barrow
Edwards Mitral Valve Replacement System SAPIEN M3 Receives CE Mark Edwards Portfolio Extended To Include Both Mitral Replacement And Repair Options “We believe [the SAPIEN M3] launch alongside PASCAL and EVOQUE will help support the company’s target of $2bn in transcatheter mitral and tricuspid therapies sales by 2030,” noted analysts from Leerink Partners.
-
1 week ago | 
insights.citeline.com | Natasha Barrow
Anglonordic 25: Pictura Bio’s One-Minute Pathogen-Identifying Diagnostic TestVISTA System Uses Charge-Based Labels To Identify Infectious Agents “Infectious disease should be treated in the community, not in hospitals,” Alex Batchelor, Pictura Bio CEO, told Medtech Insight at the Anglonordic Life Science Conference on 3 April in London.
-
2 weeks ago | 
insights.citeline.com | Natasha Barrow
Birmingham City University Develops New Defense Mechanism Against Cyberattacks On AI Systems Image Transformation Method Outperforms State-Of-The-Art Random Noise Defense AI systems used in healthcare are vulnerable to adversarial cyberattacks, which are a growing concern, said Atif Azad, a professor of AI at Birmingham City University. Azad’s research group has developed a method that trains AI to become more resilient to cyber threats through the use of random image adjustments.
-
2 weeks ago | 
insights.citeline.com | Natasha Barrow
Biotech Leader Predicts Delays On Device Approvals As FDA Makes Life-Saving Drugs Sole Priority US Regulatory Uncertainty Could Make Europe More Attractive To Life Science IndustryNawal Ouzren, Sensorion CEO and director, shared the latest industry reaction to US FDA layoffs at the McDermott Will & Emery European Health and Life Sciences Symposium in Paris. The McDermott Will & Emery European Health and Life Sciences Symposium was held in the Shangri-la hotel, Paris. (Shutterstock)
-
2 weeks ago | 
insights.citeline.com | Natasha Barrow
CardioVia Secures FDA Clearance Epicardial Access Needle ViaOneUS Commercial Launch On HorizonA concealed blunt-tip needle that can be inserted into the heart's pericardial space to treat cardiac arrhythmias has received FDA clearance, providing an alternative to catheter-based methods.
-
2 weeks ago | 
insights.citeline.com | Natasha Barrow
Anglonordic 25: Women’s Health Needs Therapeutic Success To Encourage Wider InvestmentFemtech Investment Success Is A ‘Comfort Blanket’ For The IndustryHealth tech is at the forefront of the women's health sector, securing 38% of venture capital in 2024. However, panelists at the Anglonordic Life Science Conference held 3 April asserted that a successful therapeutic breakthrough is key to gaining investor confidence and accelerating venture capital.
-
3 weeks ago | 
insights.citeline.com | Natasha Barrow
Abbott’s TriClip Reduces Severity Of Tricuspid Regurgitation Two-Year Results Confirm The Tricuspid Repair Device Also Significantly Reduces Heart Failure Hospitalization Abbott presented late-breaking data at the 2025 American College of Cardiology conference demonstrating that TriClip transcatheter edge-to-edge repair offers prolonged patient benefits compared to medical treatment alone after two years, which were not evident at one year.
-
3 weeks ago | 
insights.citeline.com | Natasha Barrow
Exact Sciences Launches Cologuard PlusNew Test Will ‘Significantly Reduce False Positives’The Cologuard Plus test has a sensitivity of 95% and a specificity of 94% for the detection of colorectal cancer; “unmatched accuracy,” according to Exact Sciences.
-
4 weeks ago | 
insights.citeline.com | Natasha Barrow
THENA Capital ‘Makes History’ As UK’s First All-Female Early-Stage Medtech Fund VC Firm Secures £27M From Investors In First Close Towards £50M Fund Only 16% of venture capital general partners in Europe are women, and only 9% of those have actual investment power. Thena Capital is aiming to "redefine the image of a venture capitalist."
-
4 weeks ago | 
insights.citeline.com | Natasha Barrow
Wired Health: ‘Early Diagnosis Often Benefits Science But Not The Patient’Neurologist And Writer Suzanne O’Sullivan Spoke On The Concept Of ‘Overdiagnosis’Early diagnosis can be “detrimental” to patients, Suzanne O'Sullivan, neurologist and author of “The Age of Diagnosis,” argued at the Wired Health conference on 18 March. "You save one life from screening 2,000 women for breast cancer, but you also treat 10 women unnecessarily," she said.
